Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Pathology and disease mechanisms in different stages of multiple sclerosis.
Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis.
Hypovitaminosis-D and EBV: no interdependence between two MS risk factors in a healthy young UK autumn cohort.
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
Tysabri (natalizumab)
Estimated incidence of multiple sclerosis among United States Armed Forces personnel using the Defense Medical Surveillance System.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain].
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Identification of VHY/Dusp15 as a Regulator of Oligodendrocyte Differentiation through a Systematic Genomics Approach.
The Spectrum of Neuromyelitis Optica (NMO) in Childhood.
Multiple sclerosis: The potassium channel KIR4.1-a potential autoantigen in MS.
Cross Cultural Validation of The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Analysis of CD4+CD8+ double positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.
Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes.
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Balance exercise for persons with multiple sclerosis using Wii games: a randomised, controlled multi-centre study.
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.
[Epidemiology and clinical assessment of spasticity in multiple sclerosis].
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Spasticity: pathophysiology, evaluation and management.

Pages